Edithistory:Tegtociclib
From EverybodyWiki Bios & Wiki
| oldid | date/time | username | edit summary |
|---|---|---|---|
| 1361895049 | 2026-06-30T18:43:04Z | Kowal2701 | [[WP:LLMPRV|Presumptive removal of LLM-generated content]], see [[Wikipedia:AI noticeboard/Archive 2#LLM edits by Noxoug1]]. Feel free to reinstate by following [[WP:LLMPRVOBJ|the procedures for disputing presumptive removal of LLM-generated content]]. |
| 1328754024 | 2025-12-21T18:08:57Z | Wolren | transparent image background |
| 1308112875 | 2025-08-27T15:17:34Z | JWBE | removed [[Category:Cyclopentyl compounds]]; added [[Category:Cyclopentanes]] using [[WP:HC|HotCat]] |
| 1307307920 | 2025-08-22T21:44:12Z | Graeme Bartlett | +[[Category:Carbamates]]; +[[Category:Pyrazolecarboxamides]]; +[[Category:Methoxy compounds]]; +[[Category:Isopropylamino compounds]]; +[[Category:Cyclopentyl compounds]] using [[WP:HC|HotCat]] ; more ids |
| 1307266122 | 2025-08-22T16:03:02Z | Sophisticatedevening | CAS not registered, rmv |
| 1307261018 | 2025-08-22T15:23:26Z | Folkezoft | General fixes via [[Wikipedia:AutoWikiBrowser|AutoWikiBrowser]], added [[CAT:O|orphan]] tag |
| 1307253671 | 2025-08-22T14:25:40Z | Boghog | consistent citation formatting |
| 1307240987 | 2025-08-22T12:32:58Z | Innerstream | /* External links */ |
| 1307240905 | 2025-08-22T12:32:08Z | Innerstream | |
| 1307238726 | 2025-08-22T12:09:41Z | Citation bot | Alter: pmc, doi. Add: pmc, doi-access, doi-broken-date. | [[:en:WP:UCB|Use this bot]]. [[:en:WP:DBUG|Report bugs]]. | Suggested by Noxoug1 | #UCB_webform 1/2 |
| 1307238586 | 2025-08-22T12:08:10Z | Noxoug1 | |
| 1307238519 | 2025-08-22T12:07:27Z | Noxoug1 | infobox |
| 1307238104 | 2025-08-22T12:02:45Z | Noxoug1 | infobox |
| 1307238001 | 2025-08-22T12:01:46Z | Noxoug1 | categories |
| 1307237936 | 2025-08-22T12:01:09Z | Noxoug1 | External links |
| 1307237863 | 2025-08-22T12:00:34Z | Noxoug1 | see also |
| 1307237795 | 2025-08-22T11:59:47Z | Noxoug1 | reg |
| 1307237739 | 2025-08-22T11:59:02Z | Noxoug1 | /* Biomarker considerations */ |
| 1307237711 | 2025-08-22T11:58:46Z | Noxoug1 | Biomarker considerations |
| 1307237670 | 2025-08-22T11:58:20Z | Noxoug1 | /* Target population */ |
| 1307237648 | 2025-08-22T11:58:05Z | Noxoug1 | Target population |
| 1307237511 | 2025-08-22T11:56:35Z | Noxoug1 | Clinical Trials |
| 1307237454 | 2025-08-22T11:55:46Z | Noxoug1 | /* Clinical development */ |
| 1307237429 | 2025-08-22T11:55:27Z | Noxoug1 | Clinical Trials |
| 1307237189 | 2025-08-22T11:52:40Z | Noxoug1 | /* Rationale for development */ expand |
| 1307237157 | 2025-08-22T11:52:14Z | Noxoug1 | Rationale |
| 1307237109 | 2025-08-22T11:51:48Z | Noxoug1 | /* Mechanism of action */ expand |
| 1307237075 | 2025-08-22T11:51:30Z | Noxoug1 | /* Mechanism of action */ expand |
| 1307236976 | 2025-08-22T11:50:34Z | Noxoug1 | mechanism of action |
| 1307236931 | 2025-08-22T11:50:11Z | Noxoug1 | lead |
| 1307236881 | 2025-08-22T11:49:40Z | Noxoug1 | infobox |
| 1307236787 | 2025-08-22T11:48:39Z | Noxoug1 | create |
